INTECH Investment Management’s Akero Therapeutics AKRO Stock Holding History

INTECH Investment Management’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-42,616	Closed	-$2.02M	–	2320
2025 Q3	$2.02M	Buy	42,616 +729	+2%	+$35.3K	0.02%	770
2025 Q2	$2.24M	Sell	41,887 -16,635	-28%	-$756K	0.02%	699
2025 Q1	$2.37M	Buy	58,522 +20,620	+54%	+$874K	0.02%	667
2024 Q4	$1.05M	Buy	37,902 +20,795	+122%	+$630K	0.01%	1108
2024 Q3	$491K	Buy	+17,107	New	+$446K	0.01%	1237

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

INTECH Investment Management's AKRO Position: Q4 2025 in Review

INTECH Investment Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 42,616 shares — an estimated $2.02M sold.

INTECH Investment Management first reported a position in AKRO in Q3 2024 and held it in 5 quarters. The position peaked at $2.37M in Q1 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

INTECH Investment Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
INTECH Investment Management sold 42,616 Akero Therapeutics shares in Q4 2025, an estimated $2.02M.
INTECH Investment Management first reported a position in Akero Therapeutics in Q3 2024 and held it in 5 quarters.
INTECH Investment Management's Akero Therapeutics position peaked at $2.37M in Q1 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on INTECH Investment Management's 13F filing for Q4 2025, filed 10 Feb 2026.